Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2022; 68(6): 31-43


T.B. Synelnyk1, O.O. Kravchenko1, O.S. Kostiuk1, O.M. Savchuk1, S.A. Sukhodolia2, L.I. Ostapchenko1

  1. Taras Shevchenko National University of Kyiv, Educational and Scientific Centre Institute of Biology and Medicine, Ukraine
  2. National Pirogov Memorial Medical University of Vinnytsya, Ukraine


The aim of our study was to evaluate the trypsin-like serine proteases (TLPs) distribution between systemic circulation and pancreatic tissue and to investigate the peculiarities of their involvement in the extracellular matrix components degradation in patients with pancreatic pathologies with electrophoretic analysis methods using. Тhe Khmelnitsky Regional Clinical Hospital patients aged 28-89 were selected for this study: 20 people with chronic pancreatitis (group CP); 20 people with pancreatic cancer (group PC); 20 conditionally healthy persons (control). Blood plasma samples and pancreatic tissue homogenates were obtained from all the patients, from which the TLPs fractions were subsequently obtained by the affinity chromatography method. The study showed that TLPs content in the blood plasma of patients with pancreatic pathologies is higher, and in tissue homogenates is lower relative to the values of the corresponding indicators in the control. Disk-electrophoresis using showed that TLPs fractions obtained from the blood plasma of patients of all studied groups contain a lot of high molecular weight (HMW) proteins, while TLPs from the pancreatic tissue homogenates of patients with pancreatic pathologies mainly consists of low molecular weight (LMW) proteins. Enzyme-electrophoresis results showed that all TLPs fractions include enzymes with fibrinogenolytic, gelatinolytic and collagenolytic activity. In plasma, the first were represented by medium molecular weight (MMW) proteins, and the last two groups included a lot of HMW proteins as well as proteins with very high molecular weight. In homogenates, fibrinogenolytic activity was characteristic for LMW proteins only, whereas gelatinases and collagenases were represented by both MMW and LMW proteins. Our results indicate the differences in the TLPs fractions components obtained from blood plasma and pancreatic tissue of patients with investigated pathologies, as well as significant distinctions in the processes of extracellular matrix remodeling under СР and РС.

Keywords: chronic pancreatitis; pancreatic cancer; trypsin- like serine proteases; electrophoresis.


  1. Kandikattu HK, Venkateshaiah SU, Mishra A. Chronic pancreatitis and the development of pancreatic can- cer. Endocrin Metab Immun Dis Drug Targets. 2020; 20(8):1182-210. CrossRef PubMed PubMedCentral
  2. Spagnolo DM, Greer PJ, Ohlsen CS, Mance S, Ellison M, Breze C, et al. Acute and chronic pancreatitis disease prevalence, classification, and comorbidities: A cohort study of the UK BioBank. Clin Translat Gastroenterol. 2022;13(1):e00455. CrossRef PubMed PubMedCentral
  3. Tagirasa R, Yoo E. Role of serine proteases at the tumor- stroma interface. Front Immunol. 2022;13:832418 CrossRef PubMed PubMedCentral
  4. Vizovisek M, Ristanovic D, Menghini S, Christiansen MG, Schuerle S. The Tumor proteolytic landscape: A challenging frontier in cancer diagnosis and therapy. Int J Mol Sci. 2021;22(5):2514. CrossRef PubMed PubMedCentral
  5. Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res. 2008;36(Database issue):D320-5. CrossRef PubMed PubMedCentral
  6. Patel S. A critical review on serine protease: Key immune manipulator and pathology mediator. Allergol Immunopathol (Madr). 2017;45(6):579-91. CrossRef PubMed PubMedCentral
  7. Magdeldin S, Moser A. Affinity Chromatography. Principles and applications. In: Affinity Chromatography. Magdeldin S (ed.). [Internet]. London: IntechOpen; 2012. CrossRef
  8. Ostapchenko L, Savchuk O, Burlova-Vasilieva N. Enzyme electrophoresis method in analysis of active components of haemostasis system. Advan Biosci Biotechnol. 2011;2:20-6. CrossRef
  9. Martin CE, List K. Cell surface-anchored serine proteases in cancer progression and metastasis. Cancer Metastas Rev. 2019;38(3):357-87. CrossRef PubMed PubMedCentral
  10. Vitte J. Human mast cell tryptase in biology and medicine. Mol Immunol. 2015;63(1):18-24. CrossRef PubMed
  11. Kumar AA, Buckley BJ, Ranson M. The urokinase plasminogen activation system in pancreatic cancer: prospective diagnostic and therapeutic targets. Biomo- lecules. 2022;12(2):152. CrossRef PubMed PubMedCentral
  12. Baluka D, Urbanek T, Lekstan A, Swietochowska E, Wiaderkiewicz R, Kajor M, et al. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. J Physiol Pharmacol. 2016;67(1): 93-101.
  13. Candido JB, Maiques O, Boxberg M, Kast V, Peerani E, Tomás-Bort E, et al. Kallikrein-related Peptidase 6 is associated with the tumour microenvironment of pancreatic ductal adenocarcinoma. Cancers (Basel). 2021;13(16):3969. CrossRef PubMed PubMedCentral
  14. Sakugawa C, Haruyama Y, Tanaka H, Fukushima T, Kawaguchi M, Kataoka H. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. BMC Res Notes. 2017;10(1):674. CrossRef PubMed PubMedCentral
  15. Fukuoka Y, Schwartz LB. Active monomers of human beta-tryptase have expanded substrate specificities. Int Immunopharmacol. 2007;7(14):1900-8. CrossRef PubMed PubMedCentral
  16. Velasco G, Cal S, Quesada V, Sánchez LM, López-Otín C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem. 2002;277(40):37637-46. CrossRef PubMed
  17. Yu Y, Prassas I, Diamandis EP. Putative kallikrein substrates and their (patho) biological functions. Biol Chem. 2014; 395(9): 931-43. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.